ProPharma Group Acquires Diamond Pharma Services

Odyssey Investment Partners Acquires ProPharma Group

September 22, 2020

Healthcare Services

Odyssey Investment Partners has agreed to acquire ProPharma Group from Linden Capital Partners. ProPharma Group, a global provider of regulatory, compliance, pharmacovigilance and medical information services headquartered in Overland Park, Kansas, will be led by CEO Dawn Sherman and the existing management team who are reinvesting alongside Odyssey to pursue organic and inorganic growth.

ProPharma Group Acquires Pharmica Consulting

October 6, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Pharmica Consulting, a life‑science consulting firm offering project management services and proprietary operations software for clinical trials. The acquisition expands ProPharma’s clinical and project‑management capabilities and enables Pharmica’s cloud‑based tools to be offered more broadly across ProPharma’s global client base.

ProPharma Group Acquires iSafety Systems

August 10, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Hyderabad-based iSafety Systems, a provider of end-to-end pharmacovigilance and safety solutions. The add-on expands ProPharma’s global pharmacovigilance capacity and regulatory/compliance capabilities, strengthening service coverage across 130+ countries.

ProPharma Group Acquires The Planet Group

May 27, 2021

Staffing & HR

ProPharma Group, a portfolio company of Odyssey Investment Partners, has reached an agreement to merge with/acquire The Planet Group. MidOcean Partners sold its majority stake in The Planet Group as part of the transaction; the combined company will expand ProPharma's global footprint and human capital services, creating a business with over 1,900 colleagues worldwide.

ProPharma Group Acquires M Squared Associates

March 16, 2022

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired M Squared Associates, a clinical, regulatory and quality consulting firm serving the medical device and diagnostic industry. The acquisition expands ProPharma's med‑tech capabilities across clinical affairs, regulatory strategy and quality systems, enabling broader end‑to‑end support for device, combination product and diagnostic clients globally.

ProPharma Group Acquires The Weinberg Group

January 28, 2019

Healthcare Services

ProPharma Group, a portfolio company of Linden Capital Partners, has acquired The Weinberg Group, a Washington, D.C.-based regulatory and compliance consultancy serving the pharmaceutical, biotech, and medical device industries. The deal expands ProPharma's pre-approval and pre-clinical regulatory capabilities and further integrates Weinberg's FDA-focused regulatory expertise into ProPharma's global life sciences compliance platform.